Clinical Trials Directory

Trials / Completed

CompletedNCT01533597

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

Comparison of the Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With OAB: A Prospective Randomized Multicenter Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Soonchunhyang University Hospital · Academic / Other
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate if the combination therapy consisting of anticholinergics plus alpha-blockers could be beneficial for women suffering from Overactive Bladder (OAB).

Detailed description

Overactive bladder (OAB) describes the symptom complex of urgency, with or without urge incontinence, usually with frequency and nocturia. The lower urinary tract is innervated by both the parasympathetic and the sympathetic nervous system, that act via muscarinic and adrenergic receptors, respectively. Antimuscarinics are mainly used for the treatment of patients with OAB, especially women. Other than antimuscarinics, a1-blockers have been shown in several clinical reports to be useful in treating DO caused by neurological diseases.

Conditions

Interventions

TypeNameDescription
DRUGSolifenacinSolifenacin (5mg, qd, oral)
DRUGSolifenacin plus TamsulosinSolifenacin (5mg, qd, oral) plus Tamsulosin (0.2mg, qd, oral)

Timeline

Start date
2010-12-01
Primary completion
2013-12-01
Completion
2014-02-01
First posted
2012-02-15
Last updated
2015-01-27
Results posted
2015-01-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01533597. Inclusion in this directory is not an endorsement.